Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Clinical Trial Protocol Amendment Summary

Known as: Prot Amend, Protocol Amendment, Summary of Changes 
A synopsis of changes to, or formal clarification of, a clinical study protocol.
National Institutes of Health

Related topics

Related topics

1 relation
Clinical trial protocol document

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Intensive spa and exercise therapy program for returning to work for low back pain patients: a randomized controlled trial
We aimed to determine whether a 5-day intensive inpatient spa and exercise therapy and educational program is more effective than… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
Discontinuing Inappropriate Medication Use in Nursing Home Residents
Polypharmacy, often defined as coincident prescribing of at least 5 long-term medications, is associated with an increased risk… Expand
Is this relevant?
Highly Cited
2017
Highly Cited
2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.
BACKGROUND The hypomethylating drugs azacitidine and decitabine have shown efficacy in myelodysplastic syndromes and acute… Expand
Is this relevant?
2016
2016
Influence of Gypsum Amendment on Methane Emission from Paddy Soil Affected by Saline Irrigation Water
To investigate the influence of gypsum application on methane (CH4) emission from paddy rice soil affected by saline irrigation… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study.
BACKGROUND Hypomethylating agents are used to treat cancers driven by aberrant DNA methylation, but their short half-life might… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.
BACKGROUND Patients with type 2 diabetes and nephropathy have high cardiorenal morbidity and mortality despite optimum treatment… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2010
Review
2010
Thromboembolieprophylaxe in der Unfallchirurgie
ZusammenfassungDie Thromboembolieprophylaxe ist fester Bestandteil der unfallchirurgischen Versorgung und beinhaltet… Expand
Is this relevant?
2010
2010
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast…
The aim of this study is to test the hypothesis that antiangiogenic treatment with sunitinib consolidation can prolong remissions… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
2006
2006
On Supporting Active User Feedback in P 3 P
We propose an extension to the P3P framework that enables a consumer and a web service to engage in active policy negotiation. In… Expand
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
A randomized trial was conducted to compare the efficacy and safety of fluconazole versus that of amphotericin B in the treatment… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE